The following summarizes some of the highlights from the Americas Committee for Treatment and Research in MS (ACTRIMS) Forum, held February 5-7, 2026 in San Diego, California.
Latest News
ACTRIMS Forum 2026 survey
February 3, 2026Help make the NeuroSens coverage of the ACTRIMS Forum 2026 relevant to you.
Complete the survey below to tell us what topics are of greatest interest to you.
PRL detected in optic chiasm
January 30, 2026A newly-published postmortem study has reported that paramagnetic rim lesions (PRL) can occur in the optic chiasm in MS patients (Lockhart et al. Neurology 2026;106:e214515). This is the first report of PRLs detected in the anterior visual pathway. PRLs are most commonly seen in periventricular and deep white-matter lesions in MS patients using 3T or 7T MRI. Read More
BTK inhibitors – a look ahead
January 20, 2026Important new data are expected this year on the efficacy and safety of Bruton’s tyrosine kinase (BTK) inhibitors, a new class of disease-modifying therapies in development for multiple sclerosis. Read More